Oxurion
Belgium - Leuven
BiotechnologyFocus: Ophthalmic Medicines
Oxurion is a life sciences company focused on Ophthalmic Medicines.
Ophthalmology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Retinal and Cognitive Dysfunction in Type 2 Diabetes
Retinal FunctionTHR-687 dose level 1
Diabetes MellitusClinical Trials (1)
NCT03666923A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
Phase 1TB-403
Solid TumorsTHR-149 dose level 1
Diabetes MellitusClinical Trials (1)
NCT03511898A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
Phase 1ocriplasmin 0.0625mg
Diabetic RetinopathyClinical Trials (1)
NCT02681809A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
Phase 2Ranibizumab 0.5mg
Diabetes MellitusClinical Trials (1)
NCT03499223A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)
Phase 2THR-149 dose level 1
Diabetes MellitusClinical Trials (1)
NCT04527107A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Phase 2THR-317 8mg
Retinal TelangiectasisClinical Trials (1)
NCT03669393A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
Phase 2THR-687 dose level 1
Diabetes MellitusClinical Trials (1)
NCT05063734A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 7 clinical trials